English Korean Chinese
ホーム > 市場調査レポート > バイオテクノロジー > オーダーメイド医療 > オーダーメイド医療の技術的トレンド分析
カテゴリ
バイオテクノロジー (1630)
オーダーメイド医療 (51)
ゲノム創薬 (203)
バイオマーカー (158)
バイオマテリアル (54)
バイオ機器 (385)
遺伝子療法/RNAi (103)
抗体/免疫 (194)
再生医療 (122)
分子標的療法 (132)
市場調査レポート

オーダーメイド医療の技術的トレンド分析

Personalized Medication - Technology Trend Analysis

発行 Technical Insights, Inc.
出版日 2006年03月 商品コード 40356
ページ情報 英文  
価格
詳細については [お問い合わせ] ボタンよりお問い合わせ下さい。

原文目次

Abstract

This research service analyzes emerging technologies in personalized medicine and their impact on the healthcare market.

Table of Contents

1 EXECUTIVE SUMMARY

  • Introduction
    • Introduction to Personalized Medication
    • Synopsis of Key Findings and Technological Trends
  • Scope and Methodology
    • Scope and Segmentation of the Research Service
    • Methodology

2 PERSONALIZED MEDICINE IN PROPHYLACTIC TREATMENT

  • Technology Primer and Key Findings
    • Technology Primer
    • Key Findings
  • Noteworthy Innovations in Companies and Universities
    • New Methods to Detect PCR SNPs and Genetic Variation/Mutation--UK
    • Genetic Studies in DNP to Help Individualize the Care of Patients with Diabetes--USA
    • Study of an EFGR Mutant to Play Important Role in Signaling Pathways Leading to Cancer--USA
    • Prognostic Marker for Staging Multiple Sclerosis Patients--Israel

3 PERSONALIZED MEDICATION IN THERAPEUTICS

  • Technology Primer and Key Findings
    • Technology Primer
    • Key Findings
  • Noteworthy Innovations in Companies and Universities
    • Genetic Profile of EE to Help in Developing New Ways of Therapeutics--USA
    • Gene Expression Pattern to Improve Diagnosis and Treatment of Interstitial Lung Disease--USA
    • Assay for Targeted Cancer Therapy--USA
    • Novel Method for Targeted Therapy in Non-Small Cell Lung Cancer--USA
    • Personalized Medicine in Psychiatry--Israel

4 DIAGNOSTICS IN PERSONALIZED MEDICATION

  • Technology Primer and Key Findings
    • Technology Primer
    • Key Findings
  • Noteworthy Innovations in Companies and Universities
    • A Single Diagnostic Assay to Analyze Complex Genetic Information -Germany
    • An Innovative Gene Mapping Technology to Develop Diagnostic Genetic Tests--France
    • A Diagnostic Assay Helps Identify Genetic Polymorphism in Patients with Metastatic Colorectal Cancer--USA
    • Biomarkers To Be Used in Protein Molecular Diagnostic Tests--UK
    • Lipoprotein Biomarkers for Atherosclerosis--USA
    • A Powerful Genomics Discovery Technology Platform--USA
    • CSF Biomarkers for Frontotemporal Degeneration--USA

5 SOFTWARE IN PERSONALIZED MEDICINE

  • Technology Primer and Key Findings
    • Technology Primer
    • Key Findings
  • Noteworthy Innovations in Companies and Universities
    • Biosimulation Software to Dynamics of Biological Processes Related to Cancer Progression--Israel
    • First Powerful Platform to Automate Experiments and Manage Data in Laboratories--USA
    • BioBanks to Serve as Interaction Points between Genes; Lifestyle; and Disease--USA

6 TECHNOLOGY ADOPTION FACTOR ANALYSIS

  • Technology Challenges; Accelerators; and Roadblocks
    • Challenges
    • Accelerators
    • Roadblocks
  • Future of Personalized Medication; Venture Capital Space; Mergers and Acquisitions
    • Future of Personalized Medication
    • Venture Capital Space and Insurance Policies
    • Merger and Acquisitions

7 PATENTS AND KEY CONTACTS

  • Patents
    • Patents in Prophylactic Treatment
    • Patents Related to Therapeutics
    • Patents Related to Diagnostics
  • Contact Details
    • Company Contacts
    • University Contacts

8 FROST & SULLIVAN 2006 SCIENCE AND TECHNOLOGY AWARDS

  • Excellence in Technology Award
    • Award Description
    • Award Recipient
  • Technology Innovation Award
    • Award Description
    • Award Recipient
  • Product Innovation Award
    • Award Description
    • Award Recipient

9 DECISION SUPPORT DATABASE

  • Database Tables
    • Incidence of Breast Cancer (1999-2006)
    • Incidence of Colon Rectum Cancer (1999-2006)
    • Incidence of Lung Cancer (1999-2006)
    • Incidence of Prostate Cancer (1999-2006)
    • Prevalence of Diabetes (1999-2006)
    • Percentage of Pharma R&D Expenses (1999-2006)
Back to Top